Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

被引：20
|
作者：
Trifiro, Gianluca [1 ]
Crisafulli, Salvatore [1 ]
Ando, Giuseppe [2 ]
Racagni, Giorgio [3 ]
Drago, Filippo [4 ]
机构：
[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy
[2] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[3] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy
[4] Univ Catania, Univ Hosp, Clin Pharmacol Unit, Dept Biomed & Biotechnol Sci, Catania, Italy
来源：
DRUG SAFETY | 2020年 / 43卷 / 06期
关键词：
GUIDELINES; ESC;
D O I：
10.1007/s40264-020-00935-2
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：507 / 509
页数：3
相关论文
共 50 条
  • [41] Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)
    Wu, J.
    Li, W.
    Shi, X.
    Chen, Z.
    Jiang, B.
    Liu, J.
    Wang, D.
    Liu, C.
    Meng, Y.
    Cui, L.
    Yu, J.
    Cao, H.
    Li, L.
    JOURNAL OF INTERNAL MEDICINE, 2020, 288 (01) : 128 - 138
  • [42] Abdominopelvic CT findings in patients with novel coronavirus disease 2019 (COVID-19)
    Goldberg-Stein, Shlomit
    Fink, Adam
    Paroder, Viktoriya
    Kobi, Mariya
    Yee, Judy
    Chernyak, Victoria
    ABDOMINAL RADIOLOGY, 2020, 45 (09) : 2613 - 2623
  • [43] CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement
    Samanci, Cesur
    Saylan, Bengu
    Gulsen, Gokce
    Akkaya, Yuksel
    Yesildal, Melike
    Isik, Sinem Akkaya
    Ustabasioglu, Fethi Emre
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2021, 43 (04) : 341 - 348
  • [44] Abdominopelvic CT findings in patients with novel coronavirus disease 2019 (COVID-19)
    Shlomit Goldberg-Stein
    Adam Fink
    Viktoriya Paroder
    Mariya Kobi
    Judy Yee
    Victoria Chernyak
    Abdominal Radiology, 2020, 45 : 2613 - 2623
  • [45] Diagnosis and treatment of 471 patients with 2019 novel coronavirus disease (COVID-19)
    Cheng, Kebin
    Xiong, Weining
    Zhou, Xin
    Li, Huiping
    Zheng, Junhua
    Xu, Jinfu
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (02)
  • [46] 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases
    Taxonera, Carlos
    Sagastagoitia, Inigo
    Alba, Cristina
    Manas, Norberto
    Olivares, David
    Rey, Enrique
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (02) : 276 - 283
  • [47] ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
    Daoud, Ahmed
    Ali, Hatem
    Rao, Vinaya
    Rohan, Vinayak
    Soliman, Karim
    RENAL FAILURE, 2021, 43 (01) : 1463 - 1464
  • [48] Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people Authors Reply
    Hippisley-Cox, Julia
    Tan, Pui San
    Coupland, Carol
    HEART, 2021, 107 (02) : 170 - 171
  • [49] Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease
    Tse, Gary
    Zhou, Jiandong
    Lee, Sharen
    Wong, Wing Tak
    Li, Xintao
    Liu, Tong
    Cao, Zhidong
    Zeng, Daniel Dajun
    Wai, Abraham K. C.
    Wong, Ian Chi Kei
    Cheung, Bernard Man Yung
    Zhang, Qingpeng
    JOURNAL OF HYPERTENSION, 2021, 39 (08) : 1717 - 1724
  • [50] DOES ANGIOTENSIN II RECEPTOR BLOCKERS/ANGIOTENSIN CONVERTING ENZYME INHIBITORS INCREASE THE RISK OF COVID-19 INFECTED PATIENTS?
    Karacaer, Cengiz
    Yurtsever, Zubeyir
    Dheir, Hamad
    Yaylaci, Selcuk
    Varim, Ceyhun
    Nalbant, Ahmet
    Demirci, Taner
    Kaya, Tezcan
    ACTA MEDICA MEDITERRANEA, 2022, 38 (04): : 2375 - 2379
12345